Latest News & Features
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/805eb780-39f0-11ef-ae3b-39eca959fd5a-Shutterstock_1991562455%20(2).webp)
Europe
UK leg of global litigation over mRNA tech sees patents ruled valid and invalid | Justice Meade follows EPO in decision on Moderna’s EP 565 patent | Pfizer and German partner BioNTech on the hook for EP 949 | Opinion on Moderna’s COVID pledge also handed down. 4 July 2024
Careers
New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens. 4 July 2024
Americas
Biomodal claims New England Biolabs infringed eight patents licensed by US non-profit | Cambridge-based firm produces ‘duet platform’ encompassing genetics and epigenetics. 4 July 2024
Americas
List compiled by sister title features peer-reviewed IP lawyers from across six continents | 2024 edition “most comprehensive and rigorous” to date, says rankings editor | Data reveals gender ratio and practice area concentration by continent. 2 July 2024
Americas
As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger. 2 July 2024
Europe
Double promotion includes patent attorney who challenged Novartis in G1/22 | Supplementary Protection Certificates expert also joins partnership. 2 July 2024
Big Pharma
Clarivate analysis identifies 140,000 patented inventions in digital health in decade to 2022 | Patentees comprise a ‘surprising mix’ of companies across various industries. 2 July 2024
Americas
Womble Bond Dickinson’s new South Carolina partner previously led Dority & Manning’s chemical and life sciences group. 27 June 2024
Americas
Judges considered Hikma’s label and marketing material when overturning lower court’s decision | Court said Amarin had stated plausible claim for induced infringement of patents. 27 June 2024
Americas
US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss. 25 June 2024